ConductScience.org, home

Paper41378487

Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction.

Ibrahim R and 14 others. J Am Heart Assoc, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction. Papers, record 41378487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41378487

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction.
PubMed
Journal
J Am Heart Assoc
PubMed
Year
2025
PubMed
Publication types
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-07
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ibrahim RRamzihttps://orcid.org/0000-0003-0124-9513
2Han WWilliamhttps://orcid.org/0009-0002-9343-3392
3Wang WWinstonhttps://orcid.org/0000-0003-4442-174X
4Kau EEthanhttps://orcid.org/0000-0002-1570-1630
5Said NNada
6Forst BBeani
7Pham HNHoang Nhttps://orcid.org/0000-0001-8412-0082
8Abdelnabi MMahmoud
9Salih MMohammedhttps://orcid.org/0000-0002-5916-7257
10Ali NBNima Bhttps://orcid.org/0009-0004-3979-0609
11Farina JJuan
12Lester SJSteven J
13Lee KKwanhttps://orcid.org/0000-0001-6302-9925
14Ayoub CChadihttps://orcid.org/0000-0001-5877-7478
15Arsanjani RRezahttps://orcid.org/0000-0001-7081-4286

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heart FailureMajor topic
Bariatric SurgeryMajor topic
Glucagon-Like Peptide-1 Receptor AgonistsMajor topic
ObesityMajor topic
Stroke VolumeMajor topic
Humans
Male
Female
Retrospective Studies
Aged
Middle Aged
Treatment Outcome
Incretins

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126808323Complications of bariatric surgery: Presentation and emergency management.Int J Surg2016https://conductscience.org/library/papers/26808323PubMed
238156532Impact of Bariatric Surgery on Left Ventricular Structure and Function.J Am Heart Assoc2024https://conductscience.org/library/papers/38156532PubMed
327790809
Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
Eur J Heart Fail2017https://conductscience.org/library/papers/27790809PubMed
427483064Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.JAMA2016https://conductscience.org/library/papers/27483064PubMed
540426935Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure.Biomedicines2025https://conductscience.org/library/papers/40426935PubMed
639741663Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review.Front Cardiovasc Med2024https://conductscience.org/library/papers/39741663PubMed
738587233Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.N Engl J Med2024https://conductscience.org/library/papers/38587233PubMed
838275114Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity.Circ Heart Fail2024https://conductscience.org/library/papers/38275114PubMed
928714796Effect of bariatric surgery on heart failure.Expert Rev Cardiovasc Ther2017https://conductscience.org/library/papers/28714796PubMed
1024811133Effects of GLP-1 on appetite and weight.Rev Endocr Metab Disord2014https://conductscience.org/library/papers/24811133PubMed
1138732142Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists.Int J Mol Sci2024https://conductscience.org/library/papers/38732142PubMed
1238848064Bariatric Metabolic Surgery vs Glucagon-Like Peptide-1 Receptor Agonists and Mortality.JAMA Netw Open2024https://conductscience.org/library/papers/38848064PubMed
13376226632023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.Eur Heart J2023https://conductscience.org/library/papers/37622663PubMed
1438093506Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists.ESC Heart Fail2024https://conductscience.org/library/papers/38093506PubMed
1539301908A Contemporary Review on Heart Failure with Preserved Ejection Fraction: Epidemiology, Diagnosis, and Management.Curr Cardiol Rev2025https://conductscience.org/library/papers/39301908PubMed
1639009781Bariatric metabolic surgery is associated with a lower risk for heart failure versus GLP-1RAs.Nat Med2024https://conductscience.org/library/papers/39009781PubMed
1720152253Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity.Am J Cardiol2010https://conductscience.org/library/papers/20152253PubMed
1830623143The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways.JACC Basic Transl Sci2018https://conductscience.org/library/papers/30623143PubMed
1924980665Effects of the once-weekly glucagon-like peptide-1 receptor agonist dulaglutide on ambulatory blood pressure and heart rate in patients with type 2 diabetes mellitus.Hypertension2014https://conductscience.org/library/papers/24980665PubMed
2028244632Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials.Diabetes Obes Metab2017https://conductscience.org/library/papers/28244632PubMed

See all 25 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42910211Cross-cutting circuits in heart failure with preserved ejection fraction: Integrating adipokine biology, mechanotransduction, and precision targeting.Int J Biol Sci2026https://conductscience.org/library/papers/42910211

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41378487

GET https://conductscience.org/api/papers/v1/41378487/references?page=2